AI assistant
RENT.COM.AU LIMITED — Capital/Financing Update 2007
Apr 12, 2007
65722_rns_2007-04-12_75753c2e-a73a-451c-b64f-736fbae50570.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer

COMPANY ANNOUNCEMENT $(ASK: SLT)$
RELEASE OF SHARES FROM ESCROW
Friday 13th April 2007
Pursuant to ASX Listing Rule 3.10A, and in accordance with the terms of escrow. Select Vaccines Limited hereby announces that the following securities are to be released from escrow.
- 4,000,000 fully paid Ordinary Shares (SLT) will be released from escrow on 29th April 2007, following expiration of the escrow period.
- 2,000,000 unquoted options (SLTAS), exercisable at \$0.44 on or before 29 April 2009, will be $\bullet$ released from eserow on $29th$ April 2007, following expiration of the eserow period.
On behalf of the board;
Martin Soust Managing Director
About Select Vaccines Limited
Select Vaccines listed on the ASX on 3 July 2003. It is developing products which identify and protect against infectious diseases of global and national importance and which satisfy the needs of other pharmaceutical and biotechnology companies. Select Vaccines' pipeline includes products targeting 'flu, hepatitis C, and Malaria. It is in partnership with Melbourne's Burnet Institute to commercialize research outcomes in the area of infectious disease. The Burnet Institute, established in 1986, is Australia's leading research organization in the field of infectious diseases caused by viruses and other agents.
Further information can be found on the company's website: www.selectvaccines.com.au.